Pharmaceuticals & Life Sciences Articles & Blogs

Articles & Blogs Commercial Contracts Pharma & Life Sciences

How Can an Innocent Party Take Action to Enforce Their Contractual Rights?

Thursday, 09 July 2020

What should an innocent party do if they are looking to take action against a late paying customer without breaching the contract itself?

How Can an Innocent Party Take Action to Enforce Their Contractual Rights?

Why Is the GPhC Receiving More Fitness to Practise Concerns?

Tuesday, 07 July 2020

The massive number of fitness to practise (FtP) concerns the GPhC has received are likely to be the result of the coronavirus (COVID-19) pandemic, says lawyer Andrew Andrews.

The GPhC Is Clamping Down on Online Pharmacy Owners

Articles & Blogs Pharma & Life Sciences

No Business, Like Brexit Business

Monday, 06 July 2020

As Brexit talks intensify, bio/pharma companies from both the UK and EU need to consider and aim to prepare for all scenarios.

No Data Protection Impact Assessment Conducted on Coronavirus Test and Trace

Thursday, 11 June 2020

The Open Rights Group (ORG) has filed a complaint with the Information Commissioner's Office about the NHS test and trace service. The complaint relates to the fact that a Data Protection Impact Assessment (DPIA) has not been carried out.

No Data Protection Impact Assessment Conducted on Coronavirus Test and Trace

UK Shows Itself As Leader in the Fight Against Coronavirus

Thursday, 11 June 2020

On 4 June 2020, the UK hosted the Global Vaccine Summit, at which Boris Johnson told attendees that events such as these were vital to the fight against coronavirus (COVID-19).

UK Shows Itself As Leader in the Fight Against Coronavirus

Genomics England Takes the Fight Against Coronavirus to the Genetic Level

Thursday, 11 June 2020

Genomics England has announced a new nationwide programme in which it will seek to study the genetic factors which play a part in an individual's susceptibility to coronavirus (COVID-19).

Genomics England Takes the Fight Against Coronavirus to the Genetic Level

UK Life Sciences Organisations to Share in €117m of Coronavirus Research Funding

Monday, 01 June 2020

Six UK-based organisations are to receive a share in €117m worth of research funding that has been awarded to eight collaborative research projects focused on the "development of therapeutics and diagnostics which are aimed at combatting coronavirus".

UK Life Sciences Organisations to Share in €117m of Coronavirus Research Funding

UK Life Sciences Industry Commits to Fighting Coronavirus and Supporting Patients

Thursday, 21 May 2020

A bold statement of intent has been issued by trade bodies representing organisations across the entire UK life sciences industry. The statement expresses the industry's strong commitment to fighting coronavirus (COVID-19) and supporting NHS patients.

UK Life Sciences Industry Commits to Fighting Coronavirus and Supporting Patients

Articles & Blogs Pharma & Life Sciences

Employer Not Vicariously Liable for Employee's Data Breach

Tuesday, 05 May 2020

In a recent decision, the Supreme Court has ruled that the supermarket chain Morrisons was not vicariously liable for its employee's malicious data breach.

Employer Not Vicariously Liable for Employee's Data Breach

The Post-Brexit Immigration System - What Do Pharma Businesses Need To Do?

Tuesday, 05 May 2020

The Government has reminded employers of the need to prepare for proposed changes to the immigration system - to be introduced in autumn 2020.

The Post-Brexit Immigration System - What Do Pharma Businesses Need To Do?

Can Essential Medical Shortages Be Prevented? The EMA May Have a Solution

Thursday, 16 April 2020

We recently reported that the European Medicines Agency (EMA) issued a statement to show that it was closely monitoring the impact of coronavirus (COVID-19) on the pharmaceutical supply chain within Europe.

Can Essential Medical Shortages Be Prevented? The EMA May Have A Solution

Coronavirus Outbreak Brings an Increase In Counterfeit Medicines and Devices

Monday, 30 March 2020

Suppliers of counterfeit medicines and medical devices are exploiting public fears around coronavirus (COVID-19), warns the Medicines and Healthcare products Regulatory Agency (MHRA), the UK's medicines and medical devices regulator.

Coronavirus Outbreak Brings an Increase In Counterfeit Medicines and Devices

How to Manage Clinical Trials During the Coronavirus Pandemic

Friday, 27 March 2020

Five key takeaways from new MHRA guidance.

How to Manage Clinical Trials During the Coronavirus Pandemic

Pharmacies Face Unprecedented Demand as Coronavirus Pandemic Continues

Thursday, 26 March 2020

Whilst the supply chain for medicines in the UK is generally holding up well during the coronavirus (also known as COVID-19) pandemic, pharmacies are facing unprecedented demand - just as with supermarkets.

Pharmacies Face Unprecedented Demand as Coronavirus Pandemic Continues

Is the Coronavirus Causing Medicine Shortages?

Tuesday, 24 March 2020

The European Medicines Agency has issued a statement to show that it is closely monitoring the impact of the coronavirus (also known as COVID-19) on the pharmaceutical supply chain within Europe.

Is the Coronavirus Causing Medicine Shortages?

Pharma & Life Sciences

Share this page: